Comparation effect of dexamethason with budsonide on reduction post extubation stridor in ICU patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201110025426N4

Enrollment

Registered

2011-11-12

Start date

2011-08-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post extubation stridor. Oedema of larynx

Interventions

Intervention 1: we administer intravenous dexametazon (8mg/every8h) for Patients who were in Group 1 from 24 hours befor extubation to 24 hours after extubation. Intervention 2: we administer Bodeson

Treatment - Drugs

we administer intravenous dexametazon (8mg/every8h) for Patients who were in Group 1 from 24 hours befor extubation to 24 hours after extubation

we administer Bodesonide by aerosolized nebuliser(0.5mg/every6h) for Patients who were in Group 2 from 24 hours befor extubation to 24 hours after extubation

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients' age 18-55 years old; intubation duration more than 48 hours and negative cuff leak test, Exclusion criteria: use of corticosteroids; history of chronic cardiopulmonary diseases, Diabetes mellitus, Gastro intestinal ulcers; patients who reintubated after extubation for other reasons such as: respiratory failure due to muscle weakness, massive airway secretions, sepsis and GCS<8.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Post extubation stridor. Timepoint: Up to 24 hours after extubation. Method of measurement: Stridor Scoring system.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mehdi Ahmadinejad

Kerman University of Medical Sciences

mehdia50@gmail.com+98 34 1222 8034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026